期刊文献+

胰腺导管内乳头状黏液性肿瘤的病理分类及诊治现状

下载PDF
导出
摘要 胰腺导管内乳头状黏液性肿瘤(intraductal papillary mucinous neoplasms,IPMNs)是最常见的胰腺囊性肿瘤。IPMNs以胰腺导管内上皮乳头样增生及分泌大量黏蛋白为特点,一般根据不同的位置分为主胰管型、分支胰管型、混合型。IPMNs的治疗需综合考虑各方面因素,包括患者的预期寿命、身体状况、治疗意愿、依从性、随访的条件等加以综合评估,最后形成个体化的治疗方案。近年对IPMNs的病理特征、诊断、处理原则等方面均有了新的认识,本文就IPMNs的研究进展作一综述。
出处 《实用肿瘤杂志》 CAS 2014年第3期280-283,共4页 Journal of Practical Oncology
基金 佳木斯大学青年基金项目(Sq2013-024)
  • 相关文献

参考文献5

二级参考文献80

  • 1Sohail MA,Saif MW.Role of anticoagulation in the management of pancreatic cancer.JOP,2009,10:82-87.
  • 2Riess H,Pelzer U,Deutschinoff G,et al.A prospective,randomized trial of chemotherapy with or without the low molecular weight heparin enoxaparin in patients with advanced pancreatic cancer:Results of the CONKO 004 trial.J Clin Oncol,2009,27:4506.
  • 3Riess H,Pelzer U,Hilbig A,et al.Rationale and design of PROSPECT-CONKO 004:a prospective,randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy.BMC Cancer,2008,8:361.
  • 4Burris HA 3rd,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial.J Clin Oncol,1997,15:2403-2413.
  • 5Heinemann V,Labianca R,Hinke A,et al.Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer:pooled analysis of two randomized trials,the GERCOR/GISCAD intergroup study and a German multicenter study.Ann Oncol,2007,18:1652-1659.
  • 6Heinemann V,Boeck S,Hinke A,et al.Meta-analysis of randomized trials:evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.BMC Cancer,2008,8:82.
  • 7Colucci G,Labianca R,Di Costanzo F,et al.A randomized trial of gemcitabine (G) versus G plus cisplatin in chemotherapy-naive advanced pancreatic adenocarcinoma:The GIP-1 (Gruppo Italiano Pancreas-GOIM/GISCAD/GOIRC) study.J Clin Oncol,2009,27:4504.
  • 8Bernhardt SL,Gjertsen MK,Trachsel S,et al.Telomerase peptide vaccination of patients with non-resectable pancreatic cancer:A dose escalating phase Ⅰ / Ⅱ study.Br J Cancer,2006,95:1474-1482.
  • 9Buanes T,Maurel J,Liauw W,et al.A randomized phase Ⅲ study of gemcitabine (G) versus GV1001 in sequential combination with G in patients with unresectable and metastatic pancreatic cancer.J Clin Oncol,2009,27:4601.
  • 10Heinemann V,Vehling-Kaiser U,Waldschmidt D,et al.Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine:Interim toxicity analysis of a multicenter,randomized,cross-over phase Ⅲ trial of the Arbeitsgemeinschaft Internistische Onkologie.J Clin Oncol,2009,27:4604.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部